Baird Maintains Outperform on Insulet, Raises Price Target to $170

Baird maintains Insulet (NASDAQ:PODD) with a Outperform and raises the price target from $165 to $170.

Benzinga · 11/06/2019 13:53

Baird maintains Insulet (NASDAQ:PODD) with a Outperform and raises the price target from $165 to $170.